| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/08/2005 | EP1536768A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 06/08/2005 | EP1536767A1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 06/08/2005 | EP1441769B1 Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections |
| 06/08/2005 | EP1339418A4 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 06/08/2005 | EP1265595B1 Stabilized ascorbic acid solutions |
| 06/08/2005 | EP1251858B1 Podophyllotoxin compositions |
| 06/08/2005 | EP1244472B1 Particulate vitamin composition |
| 06/08/2005 | EP1240285B1 Stabilisation of pigments and polyunsaturated oils and oil concentrates |
| 06/08/2005 | EP1239844B1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/08/2005 | EP1147148B1 Dextran-maleic acid monoesters and hydrogels based thereon |
| 06/08/2005 | EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 06/08/2005 | EP1069919B1 Stimulus sensitive gel comprising a radioisotope and methods of making such gel |
| 06/08/2005 | EP1007013B1 Parenteral pimaricin as treatment of systemic infections |
| 06/08/2005 | EP0914818B1 Intraorally rapidly disintegrable tablet |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | CN1625569A Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 06/08/2005 | CN1625414A Pharmaceutical composition |
| 06/08/2005 | CN1625413A Multifunction biocompatible hydrogel and preparation method thereof |
| 06/08/2005 | CN1625409A Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 06/08/2005 | CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 06/08/2005 | CN1625397A Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 06/08/2005 | CN1625395A Lutein/zeaxanthin for glare protection |
| 06/08/2005 | CN1625392A Composition for inhalation |
| 06/08/2005 | CN1625391A Cyclosporin-containing sustained release pharmaceutical composition |
| 06/08/2005 | CN1625390A Multi-stage oral drug controlled-release system |
| 06/08/2005 | CN1625389A Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 06/08/2005 | CN1625388A Osmotic delivery system |
| 06/08/2005 | CN1625384A Topical dapsone for the treatment of acne |
| 06/08/2005 | CN1625344A Use of multi-layer pigments in the food and pharmaceutical industry |
| 06/08/2005 | CN1625338A Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624002A Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical composition |
| 06/08/2005 | CN1623602A Vaccines |
| 06/08/2005 | CN1623551A Solid dispersion containing active component adefuwei or its salt and its preparation method |
| 06/08/2005 | CN1623543A Organic compounds |
| 06/08/2005 | CN1205248C Biodegradable poly(alkylene oxide)-poly cp-dioxanone) block polymer soluble in organic solvents, and drug delivery composition comprising same |
| 06/08/2005 | CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids |
| 06/08/2005 | CN1204925C Biodegradable multiple targeting hydroge lorientated to elon and its preparation and application |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204923C Anhydrous topical ski preparation |
| 06/08/2005 | CN1204921C Solution preparations stabilized over long time |
| 06/08/2005 | CN1204920C Antifungal medicnie synergist and its prepn and application |
| 06/08/2005 | CN1204893C Pharmaceutical composition |
| 06/08/2005 | CN1204885C Pharmaceutical composition contg. fenofibrate and preparation method |
| 06/08/2005 | CN1204882C Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 06/08/2005 | CN1204879C Transdermal therapeutic system wit hneutralized pressure sensitivity acrylic adhesive patch |
| 06/08/2005 | CN1204876C Oral biological macromolecular medicine administrating system based on biological adhesive microsphere |
| 06/08/2005 | CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 06/08/2005 | CN1204870C Dental care compositions |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903196 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 06/07/2005 | US6903071 Cartilage/bone inducing materials for reparation |
| 06/07/2005 | US6903070 Mixtures of peptide antibiotics and cyclodextrins used for prophylaxis of bacterial infections in humans |
| 06/07/2005 | US6902751 Encapsulated flavorings |
| 06/07/2005 | US6902746 Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same |
| 06/07/2005 | US6902744 Exendin agonist formulations and methods of administration thereof |
| 06/07/2005 | US6902742 Pulsatile delivery of methylphenidate to treat attention deficit disorder |
| 06/07/2005 | US6902740 Pyrrolidonoethyl (meth)acrylate containing pressure sensitive adhesive compositions |
| 06/07/2005 | US6902737 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields |
| 06/07/2005 | CA2464258C Compositions containing piperacillin and tazobactam useful for injection |
| 06/07/2005 | CA2348953C Cushioning wax beads for making solid shaped articles |
| 06/07/2005 | CA2336815C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/02/2005 | WO2005049211A2 Fiber rich fraction of trigonella foenum-graceum seeds and its use as a pharmaceutical excipient |
| 06/02/2005 | WO2005049091A2 Antibody-targeted nanoparticulate active agent delivery |
| 06/02/2005 | WO2005049089A2 Use of perfluoropolyethers phosphates as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions |
| 06/02/2005 | WO2005049081A1 The use of anti biotics as vaccine adjuvants |
| 06/02/2005 | WO2005049079A1 Viscous, non-polymorphic, non-water soluble liquid adjuvants |
| 06/02/2005 | WO2005049078A2 Immunoglobulin preparations having increased stability |
| 06/02/2005 | WO2005049069A1 Excipients in drug delivery vehicles |
| 06/02/2005 | WO2005049067A1 Isolated complexes of endotoxin and md-2 |
| 06/02/2005 | WO2005049061A2 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 06/02/2005 | WO2005049059A1 Perfume for improving the behavior of demented elders |
| 06/02/2005 | WO2005049048A1 Fiber rich fraction of trigonella foenum-graecum and its use as a pharmaceutcal excipient |
| 06/02/2005 | WO2005049025A1 Method and composition for treatment of cutaneous lesions |
| 06/02/2005 | WO2005049017A1 Anti-inflammatory, regenerating and antimicrobial composition |
| 06/02/2005 | WO2005049005A1 Inhibitor imaging agents |
| 06/02/2005 | WO2005048993A2 Minimization of drug oxidation in drug irradiated excipients formulations |
| 06/02/2005 | WO2005048990A2 Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer |
| 06/02/2005 | WO2005048989A1 Excipients in drug delivery vehicles |
| 06/02/2005 | WO2005048985A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 06/02/2005 | WO2005048984A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | WO2005048983A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | WO2005048977A2 Therapeutic foam comprising a sclerosing solution |
| 06/02/2005 | WO2005048976A2 Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof |
| 06/02/2005 | WO2005048949A2 Rescue agents for treating botulinum toxin intoxications |
| 06/02/2005 | WO2005048944A2 Activatable photodynamic therapy agents |
| 06/02/2005 | WO2005048930A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 06/02/2005 | WO2005048919A2 Preventative effects of morinda citrifolia on mammary breast cancer |
| 06/02/2005 | WO2005048822A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 06/02/2005 | WO2005032470A3 Compositions and methods for treating burns |
| 06/02/2005 | WO2005030253A9 Photocleavable dna transfer agent |
| 06/02/2005 | WO2005026325A3 Bivalent targeting of cell surfaces |
| 06/02/2005 | WO2005016225A3 Stable pharmaceutical composition of rabeprazole |
| 06/02/2005 | WO2004096136A3 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 06/02/2005 | WO2004034975A3 Sustained release profile modification |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | WO2003070823A9 Conjugates comprising a biodegradable polymer and uses therefor |
| 06/02/2005 | US20050119502 (Dialkylamino, morpholino, or imidazolyl)-alkoxyphenolic derivatives as drug delivery agents; improved bioavailability for oral administration |